Neural Regeneration Research ›› 2025, Vol. 20 ›› Issue (4): 1094-1095.doi: 10.4103/NRR.NRR-D-24-00187
Previous Articles Next Articles
Natalia Kulesskaya, Kira M. Holmström, Henri J. Huttunen*
Online:
Published:
Contact:
Supported by:
Abstract: Neurotrophic factors as a therapeutic approach in neurodegenerative diseases: A major unmet need in the field of central nervous system diseases is disease-modifying treatments. While for decades there have been various symptomatic treatments available to alleviate the symptoms of the disease, disease-modification, i.e. treatments that stop, significantly delay, or reverse the progression of the disease, has been turned out to a difficult goal to achieve.
Natalia Kulesskaya, Kira M. Holmström, Henri J. Huttunen. Brain-penetrating neurotrophic factor mimetics: HER-096 as a disease-modifying therapy for Parkinson’s disease[J]. Neural Regeneration Research, 2025, 20(4): 1094-1095.
0 / / Recommend
Add to citation manager EndNote|Reference Manager|ProCite|BibTeX|RefWorks
URL: https://www.sjzsyj.com.cn/EN/10.4103/NRR.NRR-D-24-00187
https://www.sjzsyj.com.cn/EN/Y2025/V20/I4/1094